Skip to content
HowShorted

Synergy Pharmaceuticals, Inc. short interest in 2018

In 2018, Synergy Pharmaceuticals, Inc.'s disclosed short interest ran from 35.75% of shares outstanding on 12 Jan 2018 to 18.28% on 14 Dec 2018, a change of -17.47 percentage points. The year's high was 35.75% on 12 Jan 2018 and its low 17.95% on 15 Nov 2018, averaging 24.55% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 35.24 days on 13 Jul 2018. Full history: Synergy Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX
Aggregate net short position time series for Synergy Pharmaceuticals, Inc. in 2018

2018 in figures

Start of year
35.75% (12 Jan 2018)
End of year
18.28% (14 Dec 2018)
Change
-17.47 pp
High
35.75% (12 Jan 2018)
Low
17.95% (15 Nov 2018)
Average
24.55%
Highest days to cover
35.24 (13 Jul 2018)
SEC filings marked
8

Every report in 2018

Synergy Pharmaceuticals, Inc. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 201835.75%11.63
31 Jan 201834.01%8.50
15 Feb 201829.41%11.18
28 Feb 201827.80%16.66
15 Mar 201825.09%13.1810-K filed, results (8-K)
29 Mar 201824.48%14.48
13 Apr 201824.91%16.93
30 Apr 201825.31%25.24
15 May 201825.39%13.7810-Q filed, results (8-K)
31 May 201824.88%23.52
15 Jun 201825.52%13.38
29 Jun 201822.24%16.88
13 Jul 201822.30%35.24
31 Jul 201822.78%26.74
15 Aug 201823.64%21.84results (8-K), 10-Q filed
31 Aug 201823.70%27.60
14 Sep 201823.23%27.20
28 Sep 201823.76%25.29
15 Oct 201824.34%20.98
31 Oct 201820.53%5.18
15 Nov 201817.95%8.6410-Q filed, results (8-K)
30 Nov 201819.38%14.94
14 Dec 201818.28%2.25

See also: Synergy Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.